Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Infante

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
BMC Neurology|February 26, 2016
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progressionDiego Santos-García, Pablo Mir, Esther Cubo, et al.
Journal of Neurology|October 23, 2019
POLR3A-related spastic ataxia: new mutations and a look into the phenotypeJon Infante, Karla M Serrano-Cárdenas, Marc Corral-Juan, et al.
Plos One|October 21, 2014
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseCarles Gaig, Dolores Vilas, Jon Infante, et al.
Neurology|January 18, 2013
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson diseaseMaria Sierra, Pascual Sánchez-Juan, María Isabel Martínez-Rodríguez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2018
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in SpainRubén Fernández-Santiago, Alicia Garrido, Jon Infante, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 21, 2020
MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered PathwaysAlexandra Pérez-Soriano, Paloma Bravo, Marta Soto, et al.
Parkinsonism & Related Disorders|December 18, 2022
Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutationAndrea Cerveró, Antonio Sánchez-Rodríguez, María Rivera-Sánchez, et al.
European Journal of Neurology|August 18, 2021
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years' follow-upAntonio Sánchez-Rodríguez, Isabel Martínez-Rodríguez, Pascual Sánchez-Juan, et al.
Annals of Neurology|October 1, 2016
Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1Kristien Peeters, Paulius Palaima, Ana L Pelayo-Negro, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2013
Genetic variability related to serum uric acid concentration and risk of Parkinson's diseaseIsabel González-Aramburu, Pascual Sánchez-Juan, Silvia Jesús, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
BMC Neurology|February 26, 2016
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progressionDiego Santos-García, Pablo Mir, Esther Cubo, et al.
Journal of Neurology|October 23, 2019
POLR3A-related spastic ataxia: new mutations and a look into the phenotypeJon Infante, Karla M Serrano-Cárdenas, Marc Corral-Juan, et al.
Plos One|October 21, 2014
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's diseaseCarles Gaig, Dolores Vilas, Jon Infante, et al.
Neurology|January 18, 2013
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson diseaseMaria Sierra, Pascual Sánchez-Juan, María Isabel Martínez-Rodríguez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2018
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in SpainRubén Fernández-Santiago, Alicia Garrido, Jon Infante, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 21, 2020
MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered PathwaysAlexandra Pérez-Soriano, Paloma Bravo, Marta Soto, et al.
Parkinsonism & Related Disorders|December 18, 2022
Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutationAndrea Cerveró, Antonio Sánchez-Rodríguez, María Rivera-Sánchez, et al.
European Journal of Neurology|August 18, 2021
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years' follow-upAntonio Sánchez-Rodríguez, Isabel Martínez-Rodríguez, Pascual Sánchez-Juan, et al.
Annals of Neurology|October 1, 2016
Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1Kristien Peeters, Paulius Palaima, Ana L Pelayo-Negro, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2013
Genetic variability related to serum uric acid concentration and risk of Parkinson's diseaseIsabel González-Aramburu, Pascual Sánchez-Juan, Silvia Jesús, et al.
Pageof 15